CPC A61K 47/61 (2017.08) [A61K 9/0019 (2013.01); A61K 9/08 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/26 (2013.01); A61K 47/40 (2013.01); A61K 47/55 (2017.08); A61P 19/02 (2018.01); A61M 5/178 (2013.01)] | 13 Claims |
1. A pharmaceutical composition, comprising a compound represented by the following formula (1) and a component (A):
the component (A): at least one type of compound selected from the group consisting of a nonionic surfactant, a hydroxyalkylated cyclodextrin, a C1 to C3 mono-alcohol, a C2 to C3 di-alcohol, a C3 to C6 tri-alcohol, a polyalkylene glycol, a γ-lactone, polyvinylpyrrolidone, a chlorogenic acid, and an alkyl sulfate ester, and salts thereof:
wherein a is 0.01 or more and 0.7 or less, a+b is 1, n is an integer of 25 or more and 25,000 or less, respective constituent disaccharide units may be arranged in a random or block form, and R is each independently a carboxy group or a carboxylate salt group in the respective constituent disaccharide unit.
|